roundup herbi blok długo działający Ścieżki i podjazdy
evergreen garden care uk ltd. archipelago, lyon way, gu16 7er frimley, wielka brytania - glifosat; diflufenikan - glifosat - 125 g, diflufenikan - 20 g - chwastobójczy
roundup herbi blok h długo działający
evergreen garden care uk ltd. archipelago, lyon way, gu16 7er frimley, wielka brytania - glifosat; diflufenikan - glifosat - 3,6 g, diflufenikan - 0,576 g - chwastobójczy
substral naturen Ślimakol
evergreen garden care uk ltd. archipelago, lyon way, gu16 7er frimley, wielka brytania - fosforan iii żelaza - fosforan iii żelaza - 10 g - moluskocyd
mastana
upl europe ltd. the centre 1 st floor, wa3 6yn birchwood park, warrington, anglia - mankozeb - 500 g - fungicyd
provanto care
evergreen garden care poland sp. z o.o. ul. ostrobramska, 04-041 warszawa - acetamipryd - 4 % - insektycyd
slugkiller granulki
evergreen garden care uk ltd. archipelago, lyon way, gu16 7er frimley, wielka brytania - fosforan iii żelaza - 10 g - moluskocyd
unizeb gold
upl europe ltd. the centre 1 st floor, wa3 6yn birchwood park, warrington, anglia - mankozeb - 500 g - fungicyd
vigor gold 100 fs
rudnikagro sp. z o.o. ul. pomorska, 70-812 - fludioksonil - 25 g, difenokonazol - 25 g, sedaksan - 50 g - fungicyd
sarclisa
sanofi winthrop industrie - isatuximab - szpiczak mnogi - Środki przeciwnowotworowe - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
kesimpta
novartis ireland ltd - ofatumumab - stwardnienie rozsiane, Рецидивно-znika - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.